| License: Creative Commons Attribution 3.0 PDF - Published Version (234kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-295104
Alternative links to fulltext:DOI
Abstract
Background 5-Fluorouracil (5-FU) is an antimetabolite, which is frequently used as chemotherapeutic agent for combined chemoradiotherapy. The purpose of this study was to present the clinical course of three patients who developed severe cardiac toxicity by 5-FU and to give a review of the literature on the cardiotoxic potential of 5-FU. Results Cardiotoxicity is a rare, but relevant side ...
Owner only: item control page
Download Statistics